Publications by authors named "David Egging"

Claim this Profile
U
Unraveling the Interaction between Carboxylesterase 1c and the Antibody-Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout Mice.
Ruud Ubink, Eef H C Dirksen, Myrthe Rouwette, Ebo S Bos, Ingrid Janssen, David F Egging

Mol Cancer Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity and drug tolerance of antidrug antibody assays in relation to positive control characteristics.
David Egging, Jos Verhagen, Karin de Laat-Arts, Benny de Wit, Tinie van Boekel

Bioanalysis· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feedback from the European Bioanalysis Forum: focus workshop on current analysis of immunogenicity: best practices and regulatory hurdles.
Joanne Goodman, Simon Cowen, Viswanath Devanarayan, David Egging, Thomas Emrich

Bioanalysis· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from branded to generic glatiramer acetate: 15-month GATE trial extension results.
Krzysztof Selmaj, Frederik Barkhof, Anna N Belova, Christian Wolf, Evelyn Rw van den Tweel, David F Egging

Mult Scler· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid screening of IgG quality attributes - effects on Fc receptor binding.
Karin P M Geuijen, Cindy Oppers-Tiemissen, David F Egging, Peter J Simons, Louis Boon

FEBS Open Bio· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Buffer and Ligand Screening for Affinity Chromatography by Multiplexed Surface Plasmon Resonance Imaging.
Karin P M Geuijen, Daniëlle E J W van Wijk-Basten, David F Egging, Richard B M Schasfoort, Michel H Eppink

Biotechnol J· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of low affinity Fcγ receptor biotinylation under controlled reaction conditions by mass spectrometry and ligand binding analysis.
Karin P M Geuijen, David F Egging, Stefanie Bartels, Jan Schouten, Richard B Schasfoort

Protein Sci· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA.
Gerard Ja Rouwendal, Miranda M van der Lee, Saskia Meyer, Karli R Reiding, Jan Schouten, David F Egging

MAbs· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody-Drug Conjugate SYD985.
Ronald C Elgersma, Ruud G E Coumans, Tijl Huijbregts, Wiro M P B Menge, John A F Joosten, David F Egging

Mol Pharm· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Preclinical Profile of the Duocarmycin-Based HER2-Targeting ADC SYD985 Predicts for Clinical Benefit in Low HER2-Expressing Breast Cancers.
Miranda M C van der Lee, Patrick G Groothuis, Ruud Ubink, Monique A J van der Vleuten, Tanja A van Achterberg, David F Egging

Mol Cancer Ther· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical profile of the HER2-targeting ADC SYD983/SYD985: introduction of a new duocarmycin-based linker-drug platform.
Wim Dokter, Ruud Ubink, Miranda van der Lee, Monique van der Vleuten, Tanja van Achterberg, David Egging

Mol Cancer Ther· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of obstetric complications and uterine connective tissue in tenascin-X-deficient humans and mice.
David F Egging, Ivonne van Vlijmen-Willems, Jiwon Choi, Anita C T M Peeters, Desiree van Rens

Cell Tissue Res· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wound healing in tenascin-X deficient mice suggests that tenascin-X is involved in matrix maturation rather than matrix deposition.
David Egging, Ivonne van Vlijmen-Willems, Tomas van Tongeren, Joost Schalkwijk, Anita Peeters

Connect Tissue Res· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions of human tenascin-X domains with dermal extracellular matrix molecules.
David Egging, Franka van den Berkmortel, Glen Taylor, Jim Bristow, Joost Schalkwijk

Arch Dermatol Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome.
James Bristow, William Carey, David Egging, Joost Schalkwijk

Am J Med Genet C Semin Med Genet· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis